Eagle Asset Management’s bluebird bio BLUE Stock Holding History

Eagle Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,996	Closed	-$26.2M	–	639
2019 Q3	$26.2M	Sell	21,996 -6	-0%	-$9.16K	0.14%	209
2019 Q2	$36.3M	Buy	22,002 +192	+0.9%	+$332K	0.19%	195
2019 Q1	$44.4M	Buy	21,810 +271	+1%	+$477K	0.24%	169
2018 Q4	$27.7M	Buy	21,539 +2,903	+16%	+$4.45M	0.17%	204
2018 Q3	$35.2M	Buy	18,636 +4,943	+36%	+$10.2M	0.17%	201
2018 Q2	$27.8M	Sell	13,693 -4,055	-23%	-$9.24M	0.15%	210
2018 Q1	$39.3M	Sell	17,748 -176	-1%	-$448K	0.21%	169
2017 Q4	$41.6M	Sell	17,924 -254	-1%	-$516K	0.23%	155
2017 Q3	$29.5M	Buy	+18,178	New	+$25.4M	0.17%	204

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eagle Asset Management's BLUE Position: Q4 2019 in Review

Eagle Asset Management sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 21,996 shares — an estimated $26.2M sold.

Eagle Asset Management first reported a position in BLUE in Q3 2017 and held it in 9 quarters. The position peaked at $44.4M in Q1 2019. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

Eagle Asset Management reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
Eagle Asset Management sold 21,996 bluebird bio shares in Q4 2019, an estimated $26.2M.
Eagle Asset Management first reported a position in bluebird bio in Q3 2017 and held it in 9 quarters.
Eagle Asset Management's bluebird bio position peaked at $44.4M in Q1 2019.
274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on Eagle Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.